Integra LifeSciences Holdings Future Growth
Future criteria checks 3/6
Integra LifeSciences Holdings is forecast to grow earnings and revenue by 49.6% and 6.9% per annum respectively. EPS is expected to grow by 47.4% per annum. Return on equity is forecast to be 19.2% in 3 years.
Key information
49.6%
Earnings growth rate
47.4%
EPS growth rate
| Medical Equipment earnings growth | 16.5% |
| Revenue growth rate | 6.9% |
| Future return on equity | 19.2% |
| Analyst coverage | Good |
| Last updated | 07 May 2024 |
Recent future growth updates
Recent updates
Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 06FDA labels recall of intracranial pressure monitors by Integra as most serious
Aug 31Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance
Aug 24Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down
Aug 23Integra LifeSciences founder/former CEO dies
Aug 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,854 | 209 | 222 | 306 | 6 |
| 12/31/2025 | 1,772 | 157 | 227 | 266 | 12 |
| 12/31/2024 | 1,676 | 95 | 138 | 153 | 12 |
| 3/31/2024 | 1,530 | 40 | 61 | 130 | N/A |
| 12/31/2023 | 1,542 | 68 | 73 | 140 | N/A |
| 9/30/2023 | 1,543 | 101 | 110 | 167 | N/A |
| 6/30/2023 | 1,545 | 131 | 155 | 208 | N/A |
| 3/31/2023 | 1,562 | 172 | 200 | 246 | N/A |
| 12/31/2022 | 1,558 | 181 | 217 | 264 | N/A |
| 9/30/2022 | 1,565 | 173 | 188 | 248 | N/A |
| 6/30/2022 | 1,567 | 166 | 205 | 263 | N/A |
| 3/31/2022 | 1,559 | 157 | 232 | 288 | N/A |
| 12/31/2021 | 1,542 | 169 | 264 | 312 | N/A |
| 9/30/2021 | 1,526 | 216 | 274 | 323 | N/A |
| 6/30/2021 | 1,509 | 206 | 262 | 310 | N/A |
| 3/31/2021 | 1,378 | 170 | 203 | 252 | N/A |
| 12/31/2020 | 1,372 | 134 | 140 | 204 | N/A |
| 9/30/2020 | 1,378 | 56 | 155 | 213 | N/A |
| 6/30/2020 | 1,387 | -3 | 78 | 207 | N/A |
| 3/31/2020 | 1,512 | 27 | 83 | 223 | N/A |
| 12/31/2019 | 1,518 | 50 | 97 | 231 | N/A |
| 9/30/2019 | 1,506 | 60 | 47 | 185 | N/A |
| 6/30/2019 | 1,493 | 101 | 124 | 200 | N/A |
| 3/31/2019 | 1,475 | 83 | 109 | 188 | N/A |
| 12/31/2018 | 1,472 | 61 | 122 | 200 | N/A |
| 9/30/2018 | 1,458 | 80 | 103 | 169 | N/A |
| 6/30/2018 | 1,371 | 70 | 78 | 135 | N/A |
| 3/31/2018 | 1,287 | 69 | 77 | 127 | N/A |
| 12/31/2017 | 1,188 | 65 | N/A | 115 | N/A |
| 9/30/2017 | 1,075 | 49 | N/A | 110 | N/A |
| 6/30/2017 | 1,047 | 66 | N/A | 111 | N/A |
| 3/31/2017 | 1,014 | 68 | N/A | 120 | N/A |
| 12/31/2016 | 992 | 75 | N/A | 116 | N/A |
| 9/30/2016 | 985 | 61 | N/A | 136 | N/A |
| 6/30/2016 | 958 | 9 | N/A | 108 | N/A |
| 3/31/2016 | 919 | 9 | N/A | 98 | N/A |
| 12/31/2015 | 883 | 7 | N/A | 105 | N/A |
| 9/30/2015 | 854 | 12 | N/A | 100 | N/A |
| 6/30/2015 | 827 | 53 | N/A | 111 | N/A |
| 3/31/2015 | 782 | 46 | N/A | 100 | N/A |
| 12/31/2014 | 797 | 36 | N/A | 84 | N/A |
| 9/30/2014 | 798 | 30 | N/A | 70 | N/A |
| 6/30/2014 | 814 | -10 | N/A | 70 | N/A |
| 3/31/2014 | 855 | -13 | N/A | 57 | N/A |
| 12/31/2013 | 697 | 22 | N/A | 53 | N/A |
| 9/30/2013 | 830 | -22 | N/A | 38 | N/A |
| 6/30/2013 | 827 | 21 | N/A | 35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IART's forecast earnings growth (49.6% per year) is above the savings rate (2.4%).
Earnings vs Market: IART's earnings (49.6% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: IART's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IART's revenue (6.9% per year) is forecast to grow slower than the US market (8.3% per year).
High Growth Revenue: IART's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IART's Return on Equity is forecast to be low in 3 years time (19.2%).